 |
Rolf | |
| Munich |
Based in Munich, Partner Rolf Fricker has supported Booz & Company clients with his extensive experience and insights in:
-
Strategy-based transformation and growth programs for pharmaceuticals, especially R&D-based companies as well as the biotech and generics/over-the-counter (OTC) industries
-
Marketing and sales force innovation programs, including mergers and acquisitions (M&A)
-
Commercial improvement and new commercial modeling programs
-
Key account management
-
Turnaround programs
Examples of Mr. Fricker’s corporate strategy engagements for the firm include developing a growth strategy for a top 10 pharmaceutical company based in Europe; strategic planning for the country organizations of a global top 10 pharma player; and turnaround of country affiliates for a leading global pharma company.
Mr. Fricker’s M&A projects at Booz & Company include conducting commercial due diligence for a pan-European supply chain network pharmaceutical and for the acquisition of a European generics franchise. Additional projects to which Mr. Fricker has contributed include the development of a governance structure and corresponding leadership assessment for a global generics company.
His marketing and sales projects for the firm include:
-
Developing a pan-European marketing excellence strategy for a leading pharmaceutical company
-
Conducting a relaunch in 14 European countries for a blockbuster product
-
Developing a European segmentation and targeting approach including a roll-out
-
Developing numerous country-specific marketing and sales effectiveness and improvement programs
-
Creating several post-patent strategies, especially those involving conversion to patent-protected areas
-
Developing sales force reallocation programs in Europe and Japan for a leading pharma player
-
Providing governance recommendations and implementation and handbook creation for a global key account management pharma
-
Developing launch and market access strategies for several blockbuster candidates
Prior to joining Booz & Company, Mr. Fricker held senior marketing and sales positions, including CEO of Serono Pharmaceuticals for the German-speaking area. He is a National Economist and has a diploma in national economy from the University of Freiburg.